China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Experience and HealthEconomic Optimization Strategies of Teprotumumab N01 Injection in Thyroid Eye Disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131654
Registration Time: 2026/09/04
Type: Observational study
Primary Sponsor: Peking University Shenzhen Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341057
Published by HT Digital Content Services with permission from Health Daily Digest....